Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

[Concepts, effectiveness, and perspectives of pandemic and seasonal influenza vaccines].

Grund S, Wichmann O, Mertens T, Hengel H.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jan;56(1):76-86. doi: 10.1007/s00103-012-1590-4. German.

PMID:
23275959
2.

[Pandemic influenza vaccines. How should they be designed?].

Löwer J.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1238-41. doi: 10.1007/s00103-010-1159-z. German.

PMID:
21161473
3.

Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.

Böhmer MM, Walter D, Falkenhorst G, Müters S, Krause G, Wichmann O.

BMC Public Health. 2012 Oct 31;12:938. doi: 10.1186/1471-2458-12-938.

4.

[Seasonal and pandemic influenza vaccination: coverage and attitude among private physicians in Germany].

Böhmer MM, Walter D, Ehrhardt J, Reiter S, Krause G, Wichmann O.

Gesundheitswesen. 2014 Jan;76(1):44-7. doi: 10.1055/s-0033-1343431. Epub 2013 Apr 30. German.

PMID:
23632821
6.

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, Kwindt TL, Tang P, Charest H, Fonseca K, Gubbay JB, Bastien N, Li Y, Petric M.

BMJ. 2011 Feb 3;342:c7297. doi: 10.1136/bmj.c7297.

7.

Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.

Isakova-Sivak I, Rudenko L.

Expert Rev Vaccines. 2015;14(10):1313-29. doi: 10.1586/14760584.2015.1075883. Epub 2015 Aug 6. Review.

PMID:
26289975
8.

Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.

Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, Vaux S, van der Werf S, Cohen JM, Lina B, Blanchon T, Hanslik T.

PLoS One. 2011 May 10;6(5):e19621. doi: 10.1371/journal.pone.0019621.

9.

[Variability in the reporting of adverse reactions to the pandemic and seasonal influenza vaccine: seasons 2009-2010 and 2010-2011. Valencian community, Spain].

Alguacil Ramos AM, Lluch Rodrigo JA, Portero Alonso A, Martín Ivorra R, Pastor Villalba E.

Rev Esp Salud Publica. 2012 May-Jun;86(3):241-51. Spanish.

10.
11.

[Pandemic influenza vaccines. Concepts, European mock-up licenses, and acceptance criteria].

Pfleiderer M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1242-9. doi: 10.1007/s00103-010-1161-5. German.

PMID:
21161474
12.

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.

Vaughn DW, Seifert H, Hepburn A, Dewe W, Li P, Drame M, Cohet C, Innis BL, Fries LF.

Hum Vaccin Immunother. 2014;10(10):2942-57. doi: 10.4161/21645515.2014.972149. Epub 2014 Nov 21.

PMID:
25483467
13.

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Osterholm MT, Kelley NS, Sommer A, Belongia EA.

Lancet Infect Dis. 2012 Jan;12(1):36-44. doi: 10.1016/S1473-3099(11)70295-X. Epub 2011 Oct 25. Review. Erratum in: Lancet Infect Dis. 2012 Sep;12(9):655.

PMID:
22032844
14.

Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities.

Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G, Petrie JG, Meece JK, Hall CB, Williams JV, Gargiullo P, Berman L, Shay DK; U.S. Flu-VE Network..

PLoS One. 2011;6(8):e23085. doi: 10.1371/journal.pone.0023085. Epub 2011 Aug 12.

15.

Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.

Fielding JE, Grant KA, Garcia K, Kelly HA.

Emerg Infect Dis. 2011 Jul;17(7):1181-7. doi: 10.3201/eid1707.101959.

16.

Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.

Ottóffy G, Horváth P, Muth L, Sólyom A, Garami M, Kovács G, Nyári T, Molnár D, Pauler G, Jankovics I.

Pediatr Blood Cancer. 2014 Jun;61(6):1013-6. doi: 10.1002/pbc.24893. Epub 2014 Jan 3.

PMID:
24395342
17.

[Pandemic preparedness planning. What did we learn from the influenza pandemic (H1N1) 2009?].

Schaade L, Reuss A, Haas W, Krause G.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1277-82. doi: 10.1007/s00103-010-1162-4. German.

PMID:
21161478
18.

Influenza vaccination coverage rates from 2006 to 2011 and the influence of the H1N1 pandemic on it in Austrian children.

Voitl PK, Schneeberger V.

Klin Padiatr. 2011 Jul;223(4):249-50. doi: 10.1055/s-0031-1279695. Epub 2011 May 31. No abstract available.

PMID:
21630177
19.
20.

Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.

Ahmed SS, Schur PH, MacDonald NE, Steinman L.

J Autoimmun. 2014 May;50:1-11. doi: 10.1016/j.jaut.2014.01.033. Epub 2014 Feb 19. Review.

Supplemental Content

Support Center